Literature DB >> 1699592

Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.

A M Nouri1, M E Smith, D Crosby, R T Oliver.   

Abstract

The expression of the major histocompatibility complex (MHC) class I and II antigens and lymphocyte function-associated antigen-3 (LFA-3) was investigated using immunohistochemical staining of bladder tissue sections from 18 patients with transitional cell carcinoma (TCC) and two normal bladder specimens. The expressions of HLA-A,B,C antigens varied greatly between different tumours. Complete loss was observed in one of 18 cases. Moderate to strong expression of HLA-A,B,C antigens was observed in 10 of 18 cases with the remaining seven cases showing either weak expression or expression on only a proportion of the tumour cells. Selective loss of HLA-Bw6 was seen in one of 18 cases. In many cases heterogenous and often focal expression of HLA-D products was seen. In one case tumour cells not expressing HLA-DR antigens were adjacent to strongly HLA-DR expressing non-neoplastic bladder epithelium, indicating a lack of inducible HLA-DR in the tumour cells. LFA-3 was undetectable in two of 18 cases with the remaining 16 cases showing moderate to strong expression of the molecule. These findings indicate that a substantial proportion of bladder tumours have one or more of a wide range of different alterations in the expressions of immunoregulatory molecules that could contribute to escape from immune surveillance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699592      PMCID: PMC1971473          DOI: 10.1038/bjc.1990.338

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

Review 1.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Immunohistochemical analysis of the human bladder.

Authors:  R A Gardiner; G J Seymour; M F Lavin; G M Strutton; E Gemmell; G Hazan
Journal:  Br J Urol       Date:  1986-02

3.  Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products.

Authors:  N J Stam; H Spits; H L Ploegh
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

4.  Selective loss of HLA-A,B,C locus products in colorectal adenocarcinoma.

Authors:  M E Smith; W F Bodmer; J G Bodmer
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

5.  Monoclonal antibody to HLA-A3.

Authors:  A E Berger; J E Davis; P Cresswell
Journal:  Hybridoma       Date:  1982

6.  Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia.

Authors:  M E Smith; S G Marsh; J G Bodmer; K Gelsthorpe; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

7.  Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer.

Authors:  F Momburg; T Degener; E Bacchus; G Moldenhauer; G J Hämmerling; P Möller
Journal:  Int J Cancer       Date:  1986-02-15       Impact factor: 7.396

8.  Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection.

Authors:  R Wallich; N Bulbuc; G J Hämmerling; S Katzav; S Segal; M Feldman
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

9.  The immunopathology of sequential tumor biopsies in patients treated with interleukin-2. Correlation of response with T-cell infiltration and HLA-DR expression.

Authors:  P J Cohen; M T Lotze; J R Roberts; S A Rosenberg; E S Jaffe
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

10.  Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation.

Authors:  K Hui; F Grosveld; H Festenstein
Journal:  Nature       Date:  1984 Oct 25-31       Impact factor: 49.962

View more
  7 in total

1.  CD antigens as promising tools for the functional analysis of solid tumours.

Authors:  P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Sporadic loss of leucocyte-function-associated antigen-3 (LFA-3) in colorectal carcinomas.

Authors:  K Koretz; P Schlag; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Clinical and immunological effect of intravesical interleukin-2 on superficial bladder cancer.

Authors:  A M Nouri; R Hyde; R T Oliver
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

4.  Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patients.

Authors:  A M Nouri; E Dorey; C L Davis; A Rohatiner; T A Lister; R T Oliver
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

5.  Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma.

Authors:  Yalu Zhang; Qiaofei Liu; Jingkai Liu; Quan Liao
Journal:  Cancer Cell Int       Date:  2021-06-30       Impact factor: 5.722

Review 6.  Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.

Authors:  Karthik Dhatchinamoorthy; Jeff D Colbert; Kenneth L Rock
Journal:  Front Immunol       Date:  2021-03-09       Impact factor: 7.561

7.  Correlation between class I antigen expression and the ability to generate tumour infiltrating lymphocytes from bladder tumour biopsies.

Authors:  A M Nouri; A V dos Santos; D Crosby; R T Oliver
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.